Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
Precision Drilling
PDS
(FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|
Total revenue | 1.40%15.52M | 29.54%4.81M | 35.26%15.31M | 3.72M | 4.09M | -26.07%11.32M | 15.31M |
Operating revenue | 1.40%15.52M | 29.54%4.81M | 35.26%15.31M | --3.72M | --4.09M | -26.07%11.32M | --15.31M |
Cost of revenue | 3.42%12.64M | 27.40%4.13M | 23.44%12.22M | 3.24M | 3.15M | -28.23%9.9M | 13.8M |
Gross profit | -6.59%2.88M | 44.22%682.68K | 117.89%3.09M | 473.35K | 936.68K | -6.39%1.42M | 1.51M |
Operating expense | -4.16%830.39K | 66.49%375K | -26.56%866.41K | 225.24K | 224.49K | 40.43%1.18M | 840.14K |
Selling and administrative expenses | -4.16%830.39K | 66.49%375K | -26.56%866.41K | --225.24K | --224.49K | 40.43%1.18M | --840.14K |
-Selling and marketing expense | -75.06%34.77K | -44.17%7.63K | -0.80%139.39K | --13.66K | --85.04K | -19.84%140.52K | --175.29K |
-General and administrative expense | 9.43%795.62K | 73.63%367.38K | -30.04%727.03K | --211.58K | --139.44K | 56.32%1.04M | --664.85K |
Operating profit | -7.54%2.05M | 24.01%307.68K | 835.97%2.22M | 248.12K | 712.2K | -64.78%237.32K | 673.74K |
Net non-operating interest income expense | 25.07%-151.95K | 0.82%-36.62K | 14.09%-202.78K | -36.92K | -31.72K | 22.25%-236.03K | -303.58K |
Non-operating interest expense | -12.52%134K | -16.05%31.38K | 4.71%153.19K | --37.38K | --40.55K | 51.43%146.3K | --96.61K |
Total other finance cost | -63.82%17.94K | 1,240.52%5.24K | -44.74%49.59K | ---459 | ---8.82K | -56.64%89.73K | --206.96K |
Other net income (expense) | -37,588.19%-558.57K | 199.87%1.49K | -42 | 1.75K | -218.79%-1.49K | 1.26K | |
Special income (charges) | ---656.25K | ---- | --0 | ---- | ---- | --0 | ---- |
-Write off | --656.25K | ---- | --0 | ---- | ---- | --0 | ---- |
Other non- operating income (expenses) | 6,455.64%97.68K | ---- | 199.87%1.49K | ---42 | --1.75K | -218.79%-1.49K | --1.26K |
Income before tax | -33.50%1.34M | -236.16%-287.52K | 1,035,998.46%2.02M | 211.15K | 682.22K | -100.05%-195 | 371.42K |
Income tax | -25.46%380.63K | -167.66%-36.92K | 12,581.15%510.67K | 54.56K | 171.79K | -95.93%4.03K | 98.91K |
Net income | -36.21%962.74K | -260.04%-250.6K | 35,849.22%1.51M | 156.59K | 510.43K | -101.55%-4.22K | 272.51K |
Net income continuous Operations | -36.21%962.74K | -260.04%-250.6K | 35,849.22%1.51M | --156.59K | --510.43K | -101.55%-4.22K | --272.51K |
Minority interest income | |||||||
Net income attributable to the parent company | -36.21%962.74K | -260.04%-250.6K | 35,849.22%1.51M | 156.59K | 510.43K | -101.55%-4.22K | 272.51K |
Preferred stock dividends | |||||||
Other preferred stock dividends | |||||||
Net income attributable to common stockholders | -36.21%962.74K | -260.04%-250.6K | 35,849.22%1.51M | 156.59K | 510.43K | -101.55%-4.22K | 272.51K |
Basic earnings per share | -36.21%0.1395 | -209.27%-0.0311 | 35,842.48%0.2187 | 0.0285 | 0.0755 | -101.65%-0.0006 | 0.0371 |
Diluted earnings per share | -36.21%0.1395 | -270.24%-0.0363 | 35,842.48%0.2187 | 0.0213 | 0.0695 | -101.65%-0.0006 | 0.0371 |
Dividend per share | |||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD |